BALLAST study: A multicentre, open-label, randomized-controlled, 52-week clinical trial of the efficacy and safety of luseogliflozin in older Japanese adults with type 2 diabetes receiving leucine-enriched amino acid supplementation and physical exercise programme
Takahashi, Y.; Hayashi, M.; Kato, T.; Horikawa, Y.; Tsunekawa, S.; Kuwata, H.; Seino, Y.; Ogata, R.; Murotani, K.; Yabe, D.; Kato, T.; Hayashi, M.; Daido, H.; Yamada, K.; Shimada, T.; Takami, K.; Sasaki, A.; Shibata, T.; Kawachi, S.-I.; Fushimi, N.; Niwa, H.; Horiya, T.; Nagata, K.; Ito, S.
Diabetes, Obesity and Metabolism, 2026
DOI: 10.1111/dom.70494